{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:37:45Z","timestamp":1793079465858,"version":"4.5.0"},"reference-count":28,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL153772, R01 HL171157"],"award-info":[{"award-number":["K23 HL153772, R01 HL171157"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23 DA054157"],"award-info":[{"award-number":["K23 DA054157"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use: Research and Treatment"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cocaine and methamphetamine, highly cardiotoxic stimulants, are associated with increased risks of hypertension, coronary artery disease, arrhythmias, cardiomyopathy, and stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study examines trends in stimulant-involved cardiovascular disease (CVD) mortality in the U.S. from 2014 to 2023, analyzing CVD subtypes, stimulant type, population characteristics, and years of life lost (YLL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Trend analysis of age-adjusted mortality rates using serial cross-section mortality data from 2014 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using National Vital Statistics System data, we analyzed age-adjusted mortality rates (AAMRs) where CVD was the underlying cause of death and stimulants were contributing factors. We used Joinpoint regression to estimate average annual percent change (AAPC) and compare trends across groups. We calculated YLL based on age at death and demographic-specific life expectancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 2014 to 2023, stimulant-involved CVD mortality rose sharply (AAPC: 10.1%), contrasting with stable rates of overall CVD mortality (AAPC: 0.2%). Methamphetamine-involved deaths increased faster (AAPC: 13.8%) than cocaine-involved deaths (AAPC: 6.5%). Among CVD subtypes, cerebrovascular disease showed the steepest rise (AAPC: 15.9%), followed by hypertensive (12.1%) and ischemic heart diseases (7.9%). Older adults (\u2a7e65\u2009years) exhibited the most pronounced increase in stimulant-involved CVD mortality (AAPC: 20.2%), while non-Hispanic American Indian\/Alaska Native populations experienced the highest AAPC among racial\/ethnic groups (18.1%). Stimulant-involved CVD caused nearly 1 million\u2009years of YLL, predominantly among middle-aged males (687\u2009430 YLL) and non-Hispanic White individuals (511\u2009120 YLL). Methamphetamine involvement (580\u2009570 YLL) exceeded that of cocaine (423\u2009528 YLL). Within CVD types, ischemic heart disease was the leading cause (406\u2009248 YLL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Stimulant-involved CVD mortality has surged, especially among non-Hispanic American Indian\/Alaska Native and non-Hispanic White populations and older adults, with cerebrovascular disease showing the largest increase among CVD subtypes. The findings reveal the importance of targeted prevention, screening, and intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29768357251342744","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:15:36Z","timestamp":1748268936000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Stimulant-Involved Cardiovascular Disease Mortality and Life Years Lost, 2014 to 2023"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-0463","authenticated-orcid":false,"given":"Rebecca Arden","family":"Harris","sequence":"first","affiliation":[{"name":"Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameed Ahmed M.","family":"Khatana","sequence":"additional","affiliation":[{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA USA"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana A.","family":"Glei","sequence":"additional","affiliation":[{"name":"Center for Population and Health, Georgetown University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Long","sequence":"additional","affiliation":[{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA"},{"name":"Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-022-10261-7"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256574"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001299"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDra2300160"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.10.481"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321610"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07692-1"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023663"},{"key":"e_1_3_2_10_2","unstructured":"Substance Abuse and Mental Health Services Administration. 2022 National Survey on Drug Use and Health: Detailed Tables. Published 2023. Accessed June 1 2024.\u2009https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-detailed-tables"},{"key":"e_1_3_2_11_2","unstructured":"Centers for Disease Control and Prevention National Center for Health Statistics. National vital statistics system provisional mortality on CDC WONDER Online Database. Accessed May 26 2024. http:\/\/wonder.cdc.gov\/mcd-icd10-provisional.html."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030969"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:131005"},{"key":"e_1_3_2_14_2","first-page":"178","article-title":"Improving validity of cause of death on death certificates","volume":"2018","author":"Hoffman RA","year":"2018","unstructured":"Hoffman RA, Venugopalan J, Qu L, Wu H, Wang MD. Improving validity of cause of death on death certificates. ACM BCB. 2018;2018:178-183.","journal-title":"ACM BCB"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268566"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283879"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:113096"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:133703"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/170564"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0000000000000550"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108369"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109001"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12024-023-00678-3"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/0025802420986707"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1279477"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2021.03.004"},{"issue":"2","key":"e_1_3_2_27_2","article-title":"Psychosocial interventions for stimulant use disorder","volume":"2","author":"Minozzi S","year":"2024","unstructured":"Minozzi S, Saulle R, Amato L, Traccis F, Agabio R. Psychosocial interventions for stimulant use disorder. Cochrane Database Syst Rev. 2024;2(2):CD011866.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001299"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107078"}],"container-title":["Substance Use: Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357251342744","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29768357251342744","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357251342744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:53:14Z","timestamp":1777600394000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29768357251342744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":28,"alternative-id":["10.1177\/29768357251342744"],"URL":"https:\/\/doi.org\/10.1177\/29768357251342744","relation":{},"ISSN":["2976-8357","2976-8357"],"issn-type":[{"value":"2976-8357","type":"print"},{"value":"2976-8357","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"article-number":"29768357251342744"}}